Evidence map›Paper›PMID 39446726›Full record

ArticlePloS one2024

Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.

Nor Asiah Muhamad, Norliza Chemi, Nur Hasnah Ma'amor, Izzah Athirah Rosli, Fatin Norhasny Leman, Mohd Fadzli Mohamad Isa, Mohammad Zabri Johari, Norni Abdullah, Nor Ashikin Ibrahim, Huan-Keat Chan and 2 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nor Asiah MuhamadSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.ORCID https://orcid.org/0000-0002-7772-2103
Norliza ChemiDepartment of Psychiatry, Kajang Hospital, Ministry of Health, Selangor, Malaysia.
Nur Hasnah Ma'amorSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.
Izzah Athirah RosliSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.
Fatin Norhasny LemanSector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.
Mohd Fadzli Mohamad IsaDepartment of Psychiatry, Kuala Lumpur Hospital, Ministry of Health, Kuala Lumpur, Malaysia.
Mohammad Zabri JohariInstitute for Behavioural Health Research, National Institutes of Health, Ministry of Health, Selangor, Malaysia.ORCID https://orcid.org/0000-0002-8017-622X
Norni AbdullahDepartment of Psychiatry, Tengku Ampuan Rahimah Hospital, Ministry of Health, Selangor, Malaysia.
Nor Ashikin IbrahimNational Centre of Excellence for Mental Health, Cyberjaya, Malaysia.
Huan-Keat ChanClinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Kedah, Malaysia.
Muhammad Radzi Abu HassanClinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Kedah, Malaysia.
My Substance Abuse Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance abuse admission to health facilities following the pandemic is often met with challenges. COVID-19 is causing an insurmountable psychosocial impact on the whole of mankind. Marginalized communities, particularly those with substance use disorders (SUDs), are also likely to suffer from greater psychosocial burden.

objectivesThis study sought to evaluate substance abuse trends before and during the pandemic.

methodsA cross-sectional study was conducted among patients attending selected government hospitals in Malaysia. Data from the year 2018 to 2021 was utilized.

resultsA total of 9,606 patients consisting of 7881 males and 1725 females were identified. Most of the patients involved with substance abuse from 2018 to 2021 were males, aged between 26 and 44 years old, Malays, high school students, singles, workers of private sectors and those residing in urban areas. The most abused substances over the four years were tobacco (61.8%), followed by amphetamine-type stimulants (ATS) (43.1%), alcohol (39.7%), cannabis (17.2%), opioids (13.0%), and kratom (8.8%). Those who worked in the private sector and were self-employed or unemployed were more associated with substance abuse during the pandemic compared to those who worked in the government sector. Those with a history of psychiatric illness were more associated with abuse of substances during the pandemic than those without the history (adjusted OR: 1.18, 95% CI 1.09-1.29, p <0.001).

conclusionsTargeted exploration of factors affecting substance abuse in Malaysia is essential. The results of this study assist in identifying variations in substance abuse treatment characteristics for those admitted to treatment in Malaysia.

Indexed as

COVID-19Substance-Related DisordersAdolescentAdultCross-Sectional StudiesFemaleHospitals, PublicHumansMalaysiaMaleMiddle AgedPandemicsSARS-CoV-2Young Adult

Identifiers

PMID39446726
PMCPMC11500913

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.